{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:52:09Z","timestamp":1768251129615,"version":"3.49.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00139","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T08:17:11Z","timestamp":1581668231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["von Hippel-Lindau Syndrome: Genetic Study of Case With a Rare Pathogenic Variant With Optic Nerve Hemangioblastoma, a Rare Phenotypic Expression"],"prefix":"10.3389","volume":"10","author":[{"given":"Sandra Di Felice","family":"Boratto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Augusto Soffner","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Gon\u00e7alves","family":"Priolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Vieira","family":"Botelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaques","family":"Waisberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-444-62702-5.00010-X","article-title":"Von Hippel\u2013Lindau disease","volume":"132","author":"Chittiboina","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1158\/0008-5472.CAN-14-0024","article-title":"Telomere shortening is associated with genetic anticipation in Chinese Von Hippel\u2013Lindau Disease Families","volume":"74","author":"Ning","year":"2014","journal-title":"Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15586\/jkcvhl.2018.104","article-title":"VHL-associated optic nerve hemangioblastoma treated with stereotactic radiosurgery","volume":"5","author":"Kanno","year":"2018","journal-title":"J Kidney Cancer VHL"},{"key":"B4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.5137\/1019-5149.JTN.16680-15.1","article-title":"Optic nerve hemangioblastomas? a review of visual outcomes","volume":"27","author":"Turel","year":"2017","journal-title":"Turk Neurosurg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.15586\/jkcvhl.2017.88","article-title":"A review of Von Hippel-Lindau Syndrome","volume":"4","author":"Varshney","year":"2017","journal-title":"J Kidney Cancer VHL"},{"key":"B6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-0004.2009.01281.x","article-title":"Surveillance in von Hippel-Lindau disease (vHL)","volume":"77","author":"Poulsen","year":"2010","journal-title":"Clin Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.rcl.2015.12.004","article-title":"von Hippel-Lindau Disease","volume":"54","author":"Shanbhogue","year":"2016","journal-title":"Radiol Clin North Am"},{"key":"B8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"B9","unstructured":"2018"},{"key":"B10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/humu.10212","article-title":"Human Gene Mutation Database (HGMD): 2003 update","volume":"21","author":"Stenson","year":"2003","journal-title":"Hum Mutat"},{"key":"B11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/gim.2016.195","article-title":"Genome editing in clinical genetics: points to consider\u2014a statement of the American College of Medical Genetics and Genomics","volume":"19","year":"2017","journal-title":"Genet Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"31128","DOI":"10.1038\/srep31128","article-title":"VHLdb: a database of von Hippel-Lindau protein interactors and mutations","volume":"6","author":"Tabaro","year":"2016","journal-title":"Sci Rep."},{"key":"B13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A","article-title":"Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC","volume":"13","author":"Gallou","year":"1999","journal-title":"Hum Mutat"},{"key":"B14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/00008571-200108000-00007","article-title":"Association of GSTT1 non-null and NAT1 slow\/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma","volume":"11","author":"Gallou","year":"2001","journal-title":"Pharmacogenetics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/1098-1004(200011)16:5<437::AID-HUMU9>3.0.CO;2-Q","article-title":"Comparative sequence analysis (CSA): a new sequence-based method for the identification and characterization of mutations in DNA","volume":"16","author":"Mattocks","year":"2000","journal-title":"Hum Mutat"},{"key":"B16","doi-asserted-by":"publisher","first-page":"11661","DOI":"10.1073\/pnas.95.20.11661","article-title":"pVHL(19) is a biologically active product of the von Hippel\u2013Lindau gene arising from internal translation initiation","volume":"95","author":"Iliopoulos","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm0895-822","article-title":"Tumour suppression by the human von Hippel-Lindau gene product","volume":"1","author":"Iliopoulos","year":"1995","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1093\/hmg\/4.11.2139","article-title":"Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene","volume":"4","author":"Richards","year":"1995","journal-title":"Hum Mol Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6496","DOI":"10.1073\/pnas.91.14.6496","article-title":"Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer","volume":"91","author":"Firth","year":"1994","journal-title":"Proc Natl Acad Sci USA."},{"key":"B20","doi-asserted-by":"crossref","first-page":"23757","DOI":"10.1016\/S0021-9258(17)31580-6","article-title":"Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1","volume":"269","author":"Semenza","year":"1994","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"29083","DOI":"10.1074\/jbc.270.49.29083","article-title":"Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences","volume":"270","author":"Ebert","year":"1995","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"32529","DOI":"10.1074\/jbc.271.51.32529","article-title":"Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1","volume":"271","author":"Semenza","year":"1996","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fped.2018.00016","article-title":"Renal cell carcinoma in von Hippel-Lindau Disease-from tumor genetics to novel therapeutic strategies","volume":"6","author":"Kim","year":"2018","journal-title":"Front Pediatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature."},{"key":"B25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrc3844","article-title":"VHL, the story of a tumour suppressor gene","volume":"15","author":"Gossage","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1101\/sqb.2011.76.010975","article-title":"Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases","volume":"76","author":"Kaelin","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/onc.2011.266","article-title":"The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C","volume":"31","author":"Niu","year":"2012","journal-title":"Oncogene"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1038\/onc.2012.578","article-title":"Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis","volume":"32","author":"Semenza","year":"2013","journal-title":"Oncogene"},{"key":"B29","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.bbamcr.2015.05.036","article-title":"The hypoxic tumor microenvironment: a driving force for breast cancer progression","volume":"1863","author":"Semenza","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1148\/rg.2018170156","article-title":"Tumors in von Hippel-Lindau Syndrome: from head to toe-comprehensive state-of-the-art review","volume":"38","author":"Ganeshan","year":"2018","journal-title":"Radiographics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/humu.21219","article-title":"Genetic analysis of von Hippel-Lindau disease","volume":"31","author":"Nordstrom-O'Brien","year":"2010","journal-title":"Hum Mutat."},{"key":"B33","unstructured":"26288231The Human Gene Mutation Database"},{"key":"B34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.15586\/jkcvhl.2015.41","article-title":"Implications of Von Hippel-Lindau syndrome and renal cell carcinoma","volume":"2","author":"Ashouri","year":"2015","journal-title":"J Kidney Cancer VHL"},{"key":"B35","first-page":"697","article-title":"Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease","volume":"11","author":"Chan","year":"2005","journal-title":"Mol Vis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.iae.0000244659.62202.ee","article-title":"Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review","volume":"27","author":"Chan","year":"2007","journal-title":"Retina"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1245\/s10434-013-2942-5","article-title":"Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing","volume":"20","author":"Fishbein","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1086\/302726","article-title":"Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents","volume":"66","author":"Sgambati","year":"2000","journal-title":"Am J Hum Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/cge.12092","article-title":"Mosaicism in von Hippel-Lindau disease with severe renal manifestations","volume":"84","author":"Wu","year":"2013","journal-title":"Clin Genet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jmedgenet-2011-100562","article-title":"Life expectancy in hereditary cancer predisposing diseases: an observational study","volume":"49","author":"Wilding","year":"2012","journal-title":"J Med Genet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40880-016-0141-z","article-title":"Clinical and molecular characteristics of East Asian patients with von Hippel\u2013Lindau syndrome","volume":"35","author":"Wong","year":"2016","journal-title":"Chin J Cancer."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00139\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T12:45:31Z","timestamp":1614429931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00139\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":41,"alternative-id":["10.3389\/fonc.2020.00139"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00139","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"article-number":"139"}}